Matthew Tjahja

Matthew Tjahja practices at Covenant Health Parkwest in Knoxville, Tennessee, part of Covenant Health.

Matthew Tjahja's NPI, 1467088450, was assigned on March 21, 2020. Matthew Tjahja graduated from Texas A&M College of Medicine - Bryan in 2020. Matthew Tjahja holds Texas license U2338.

Matthew Tjahja's primary practice is Covenant Health Parkwest, at 9352 Park West Blvd, Knoxville, TN 37923 in Knox County. The practice phone is (865) 970-1001.

Matthew Tjahja's primary practice is Covenant Health Parkwest in Knoxville, Tennessee, part of Covenant Health. Matthew Tjahja is also affiliated with University Hospital. The medical group on file is Texas Liver Institute. Dmand AI also links Matthew Tjahja to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Matthew Tjahja practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Matthew Tjahja's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Matthew Tjahja is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Matthew Tjahja's licenses on file in 2 states: Texas and Tennessee.

Dmand AI lists chest wall injury among the conditions Matthew Tjahja treats.

CMS data shows 120 Medicare services from Matthew Tjahja across 4 procedure codes in 2024, for 74 Medicare patients. Medicare paid $8,996 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 74 Medicare patients who saw Matthew Tjahja in 2024. The largest group is 75 to 84, with 28 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Matthew Tjahja's median patient age at 69, with 56% women.

In 2024, Matthew Tjahja wrote 119 Medicare Part D claims for 49 patients. 87% of them were for generic drugs. CMS names the drug for 31 of them, across 2 drugs with 11 or more claims each, at $395 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

Matthew Tjahja accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Matthew Tjahja, published from 2021 to 2024. 2024 was the busiest year, with 5. The most frequent topics are Disease Models, Animal and Liver. Matthew Tjahja has published most often in Proc (Bayl Univ Med Cent). Matthew Tjahja's most frequent co-authors are Mark Shell, DO, Charles Stanton Bussell, MD and Christopher Chu, MD.

CMS Open Payments shows 45 general payments to Matthew Tjahja from 9 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $453.

Matthew Tjahja graduated from Texas A&M College of Medicine - Bryan in 2020.

Matthew Tjahja is in network with 20 carriers, including Aetna, United Healthcare and Elevance. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.